Article Details
Retrieved on: 2018-03-21 20:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. raised its holdings in shares of Caladrius Biosciences Inc (NASDAQ:CLBS) by 2.8% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 155,380 shares of the biotechnology company's stock after acquiring an additional 4,163 shares during the ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here